(Q43866468)

English

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma

scientific article published in February 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

phase II clinical trial

0 references

1

object named as

H B Muss

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

N Spell

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Scudiery

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R L Capizzi

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M R Cooper

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Cruz

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D V Jackson

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

F Richards

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C L Spurr

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D R White

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 1990

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

125-130

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Toxicity of E. coli L-asparaginase in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclic combination chemotherapy of canine lymphosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-asparaginase: clinical, biochemical, pharmacological, and immunological studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary study on the evaluation of asparaginase. Polyethylene glycol conjugate against canine malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lymphosarcoma in the dog with L-asparaginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity of L-asparaginase in children with advanced leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2345067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00216938

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43866468&oldid=2206303992"